Trial Search Results

Comparison of Staples Versus Prolene Suture for Skin Closure at Cesarean Delivery

Currently different materials are used to close the skin after a cesarean delivery, including absorbable suture, non-absorbable suture and staples. It is not known what is the best choice of material to close the skin after a cesarean section, but commonly staples or dissolvable suture is used. Recently plastic surgeons have found that non-dissolvable suture may have a better cosmetic outcome than staples. The investigators hope to learn if there is a difference in pain both at suture/staple removal and 6 weeks postoperatively between Prolene suture, Absorbable suture (monocryl or vicryl) or staples. The investigators also plan to look for differences in wound complications and patient satisfaction, as well as operating and removal times. This knowledge will be important in helping practitioners choose the closure technique at cesarean delivery.

Stanford is currently not accepting patients for this trial.

Lead Sponsor:

Stanford University

Stanford Investigator(s):


  • Procedure: Staples
  • Procedure: Prolene non-absorbable sutures
  • Procedure: Absorbable Sutures




Inclusion Criteria:

   - Pregnant women undergoing primary or repeat cesarean section

   - Maternal age greater than or equal to 18 years of age

   - Gestational age greater than or equal to 34 weeks

   - Elective and non-elective cesarean section

Exclusion Criteria:

   - Type 1 or Type 2 diabetes

   - BMI greater than 35

   - Pre-operative diagnosis of chorioamnionitis

   - History of drug or alcohol abuse

   - Contraindication to NSAIDs

   - Chronic pain diagnosis

   - Narcotic use prior to pregnancy

   - Maternal age less than 18 years of age

   - General anesthesia

   - Chorioamnionitis, clinical suspicion of chorioamnionitis, or risk factors for
   chorioamnionitis (membrane rupture greater than 18 hours, GBS positive status)

   - Vertical skin incision

Ages Eligible for Study

18 Years - 55 Years

Genders Eligible for Study


Not currently accepting new patients for this trial

Contact Information

Stanford University
School of Medicine
300 Pasteur Drive
Stanford, CA 94305
Natali Aziz, MD